NitroMed nitromed.com


Public lists: Pharma Startups (4732)

NitroMed, Inc. of Lexington, Massachusetts is a pharmaceutical company and the maker of BiDil, an orally administered medicine available in the United States for the treatment of heart failure in self-identified black patients. In this population, BiDil is indicated as an adjunct to current standard therapies such as ACE inhibitors and/or beta blockers. BiDil was approved by the U.S. Food and Drug Administration, primarily on the basis of efficacy data from the Company's landmark A-HeFT (African...Show all

NitroMed, Inc. of Lexington, Massachusetts is a pharmaceutical company and the maker of BiDil, an orally administered medicine available in the United States for the treatment of heart failure in self-identified black patients. In this population, Bi...Show all

Company (Acquired)

Phone: 704-941-2020

Fax:

6000 Fairview Road
Suite 610
Charlotte, 28210
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
NitroMed $137M Dec 13, 2004
See all 26 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related NitroMed Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 11 investors

Competitors

Company Status Description Investors

National Packaging Systems

Corning, New York, United States
AcquiredNational Packaging Systems aims to provide outsourced packaging services to the clinical trial segment of the pharmaceutical industry. Login to see details

Solstice Neurosciences

Malvern, Pennsylvania, United States
AcquiredFounded in 2004, Solstice Neurosciences, Inc. is a biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty products. Solstice's first product, Myobloc (Botulinum Toxin Type B) Injectable Solution, represents the only botulinum toxin type B currently available to physicians and patients. MYOBLOC is sold in the United States and approved in Canada. It is also distributed and sold in the EU as NeuroBloc. MYOBLOC is indicated for the treatment of patient...Show allLogin to see details
See all 26 competitors